Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yinyu MU"'
Autor:
Guodong Xu, Hang Chen, Shibo Wu, Jiabin Chen, Shufen Zhang, Guofeng Shao, Lebo Sun, Yinyu Mu, Kaitai Liu, Qiaoling Pan, Ni Li, Xiaoxia An, Shuang Lin, Wei Chen
Publikováno v:
Cell Death and Disease, Vol 13, Iss 8, Pp 1-11 (2022)
Abstract Hypoxia-induced cisplatin resistance is a major challenge during non-small cell lung cancer (NSCLC) treatment. Based on previous studies, we further explored the effect of eukaryotic initiation factor 5A2 (eIF5A2) in hypoxia-induced cisplati
Externí odkaz:
https://doaj.org/article/03a10ddfc17442589234f33b7d66378e
Autor:
Hang Chen, Zeyang Hu, Menglu Sang, Saiqi Ni, Yao Lin, Chengfang Wu, Yinyu Mu, Kaitai Liu, Shibo Wu, Ni Li, Guodong Xu
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Autophagy is closely associated with the tumor immune microenvironment (TIME) and prognosis of patients with lung adenocarcinoma (LUAD). In the present study, we established a signature on the basis of long noncoding RNAs (lncRNAs) related to autopha
Externí odkaz:
https://doaj.org/article/2a918dcefbf749a59fce5a1ee63615b0
Publikováno v:
Chinese Journal of Lung Cancer, Vol 21, Iss 7, Pp 543-546 (2018)
Lung cancer is one of the most important malignant tumors of human health and life in the world, and is the leading cause of death in the world. At present, it is believed that it is caused by many factors. Circular RNA (circRNA), as a class of non-c
Externí odkaz:
https://doaj.org/article/64e00a7d3f06441484697cc6da38e9cb
Autor:
Biao Gu, Wenxin Gao, Zeqi Liu, Guangda Shao, Qin Peng, Yinyu Mu, Qinhu Wang, Hua Zhao, Jianqiang Miao, Xili Liu
Publikováno v:
Molecular Plant Pathology. 24:317-330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afed2361b37a6321bc1c35dc2c33aa1d
https://doi.org/10.1111/mpp.13298
https://doi.org/10.1111/mpp.13298
Publikováno v:
Cancer Management and Research. 14:1229-1236
Yinyu Mu,1 Fuyi Xie,1 Dongdong Yang,1 Guodong Xu2 1Department of Clinical Laboratory, Ningbo Medical Centre, Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, 315040, Peopleâs Republic of China; 2Department of Cardiothoracic Surgery, Ningbo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43030b97aa72590662a817f02ae88d61
https://doi.org/10.2147/cmar.s346616
https://doi.org/10.2147/cmar.s346616
Publikováno v:
Clinical Laboratory. 69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9b639ec85ec25bda5dec522b8b62f20
https://doi.org/10.7754/clin.lab.2022.220728
https://doi.org/10.7754/clin.lab.2022.220728
Autor:
Wei Shen, Linwen Zhu, Shibo Wu, Hang Chen, Yinyu Mu, Ni Li, Kaitai Liu, Saiqi Ni, Menglu Sang, Guodong Xu
Publikováno v:
Aging (Albany NY)
The tumor immune microenvironment of lung cancer is associated with prognosis and immunotherapy efficacy. Long noncoding RNAs are identified as prognostic biomarkers associated with immune functions. We constructed a signature comprising differential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a5aaa2b1eb5cbee174017c0105f53fd
https://doi.org/10.18632/aging.203455
https://doi.org/10.18632/aging.203455
Autor:
Zeyang Hu, Hang Chen, Hongxiang Li, Shuguang Xu, Yinyu Mu, Qiaoling Pan, Jingtao Tong, Guodong Xu
Publikováno v:
Medicine; Sep2023, Vol. 102 Issue 35, p1-14, 14p
Publikováno v:
Journal of clinical laboratory analysis. 36(8)
The purpose of this study was to explore the detection value of seven autoantibodies (TAAbs): p53, PGP9.5, SOX2, GBU4-5, MAGE A1, CAGE, and GAGE7 and three tumor markers: CYFRA21-1, NSE, and SCCA in the diagnosis of lung cancer.ELISA was used to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e47ea8d8fcb6dc12e92af84498caba2e
https://pubmed.ncbi.nlm.nih.gov/35596744
https://pubmed.ncbi.nlm.nih.gov/35596744
Autor:
Guodong Xu, Hang Chen, Shibo Wu, Jiabin Chen, Shufen Zhang, Guofeng Shao, Lebo Sun, Yinyu Mu, Kaitai Liu, Qiaoling Pan, Ni Li, Xiaoxia An, Shuang Lin, Wei Chen
Publikováno v:
Cell deathdisease. 13(8)
Hypoxia-induced cisplatin resistance is a major challenge during non-small cell lung cancer (NSCLC) treatment. Based on previous studies, we further explored the effect of eukaryotic initiation factor 5A2 (eIF5A2) in hypoxia-induced cisplatin resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16e8ecf7bb4ce93129189d1f0a75491
https://pubmed.ncbi.nlm.nih.gov/35931669
https://pubmed.ncbi.nlm.nih.gov/35931669